ABSTRACT
During October 2016-March 2022, Uganda increased tuberculosis (TB) preventive therapy coverage among persons living with HIV from 0.6% to 88.8%. TB notification rates increased from 881.1 to 972.5 per 100,000 persons living with HIV. Timely TB screening, diagnosis, and earlier treatment should remain high priorities for TB/HIV prevention programming.
Subject(s)
Acquired Immunodeficiency Syndrome , HIV Infections , Tuberculosis , Humans , Tuberculosis/diagnosis , Uganda , Mass Screening , HIV Infections/prevention & controlABSTRACT
Since the coronavirus disease pandemic response began in March 2020, tests, vaccinations, diagnoses, and treatment initiations for sexual health, HIV, and viral hepatitis in England have declined. The shift towards online and outreach services happened rapidly during 2020 and highlights the need to evaluate the effects of these strategies on health inequalities.
Subject(s)
COVID-19 , HIV Infections , Hepatitis, Viral, Human , Sexually Transmitted Diseases , England/epidemiology , HIV Infections/diagnosis , HIV Infections/epidemiology , Hepatitis, Viral, Human/epidemiology , Hepatitis, Viral, Human/therapy , Humans , Pandemics/prevention & control , SARS-CoV-2 , Sexually Transmitted Diseases/epidemiologyABSTRACT
An HIV-positive man from Zimbabwe living in South Africa sought treatment for multiple clinical signs, including fever, weight loss, anemia, and splenomegaly. We identified in his blood an African rodent piroplasm, Anthemosoma garnhami, related to Babesia species. This finding extends the known geographic and host range of A. garnhami.